Watch POAP mints live!

over 2 years ago

Loading

over 2 years ago

Loading

I’ve met Tanja at “Bayer DS&AI conference in Madrid

I am working in DS3 heading a team working in the areas of Medical Standards, Medical Coding and supporting Data Compliance topics.

over 2 years ago

I’ve met Tanja at “Bayer DS&AI conference in Madrid POAP image

Team Data Science Solution & Services Head of Statistics, Analysis & Insights Solutions Living in Cologne, Working in Wuppertal Germany Responsible for Systems like SWAN, TOSCA, BMDA and ALYCE

over 2 years ago

I’ve met Holger Dach at Bayer Global DS&AI F2F Meeting Madrid POAP image

Swapna Lingala DS&AI, India

Joined Bayer in 2019 and supporting various functions of R&D. Recently moved to DA&AI group.

over 2 years ago

Swapna Lingala DS&AI, India POAP image

over 2 years ago

Loading

Collaborations with external partners may lead to joint legal rights for compounds and data, which may restrict reusage in other projects. With the increasing number of collaborations at Bayer and with advancing time, memories of the project details fade, and reconstruction of the status will be nearly impossible. Therefore, we aim for a system to document the role of compounds, which will facilitate decisions on further usage in other collaborations. For more information contact: Miriam Wollenhaupt. Images taken from Microsoft Office free for use pictograms.

over 2 years ago

I was at the Bayer DS&AI Poster - Compound Passport POAP image

over 2 years ago

Loading

The Data Assets and Insights Solutions subfunction, DAIS, consists of a team of dedicated computer and data scientists which combine deep R&D process and domain expertise (biology, chemistry, pharmacy, etc) with advanced computational expertise (software engineering, natural language processing, scalable architectures, bio- & chem-informatics, data integration & visualization, etc). We integrate, enrich and harmonize large scientific datasets to build foundational data assets which are used by the R&D organization and our team to build insights solutions. They address key R&D challenges to improve speed, quality and probability of success of our R&D pipeline. Selected business critical tasks within R&D we are focusing on: - Target identification including holistic assessment - Disease understanding including precision medicine - Pipeline evaluation (therapeutic potential and risks) - Modality selection including identification of tool compounds - Identification of collaboration and in-licensing opportunities For more information contact: Wolfgang Thielemann. Artwork: Licensed pictures.

over 2 years ago

I was at the Bayer DS&AI Poster - Data Assets and Insights Solutions POAP image

over 2 years ago

Loading